Are patients with inflammatory bowel disease at increased risk of coronary artery disease?

American Journal of Medicine

Volumn 125, Issue 10, 2012, Pages 956-962

  Gandhi, Sumeet ^a   Narula, Neeraj ^b   Marshall, John K ^b   Farkouh, Michael ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Atherosclerosis; Coronary artery disease; Crohn's disease; Inflammatory bowel disease; Ischemic heart disease; Ulcerative colitis

Indexed keywords

C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; EMBASE; ENTERITIS; HEART DEATH; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MEDICAL LITERATURE; MEDLINE; PEER REVIEW; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CORONARY ARTERY DISEASE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATORY BOWEL DISEASES; RISK FACTORS;

EID: 84866524280     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.03.015     Document Type: Review

References (64)

1. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 16 2005 1685 1695
2. H. Eyre, R. Kahn, R.M. Robertson Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association Stroke 35 8 2004 1999 2010
3. R. McPherson, J. Frohlich, G. Fodor, J. Genest Canadian Cardiovascular Society Canadian Cardiovascular Society position statement - recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease Can J Cardiol 22 11 2006 913 927
4. R.S. Vasan, L.M. Sullivan, R. Roubenoff Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study Circulation 107 11 2003 1486 1491
5. O.A. Hatoum, D.G. Binion The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology Inflamm Bowel Dis 11 3 2005 304 313
6. C. Mowat, A. Cole, A. Windsor Guidelines for the management of inflammatory bowel disease in adults Gut 60 5 2011 571 607
7. S. Yusuf, S. Hawken, S. Ounpuu Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 9438 2004 937 952
8. D.G. Hackam, S.S. Anand Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence JAMA 290 7 2003 932 940
9. C.P. Chung, A. Oeser, I. Avalos Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis Arthritis Res Ther 8 6 2006 R186
10. H. Maradit-Kremers, C.S. Crowson, P.J. Nicola Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study Arthritis Rheum 52 2 2005 402 411
11. K.J. Warrington, P.D. Kent, R.L. Frye Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study Arthritis Res Ther 7 5 2005 R984 R991
12. E. Thomas, D.P. Symmons, D.H. Brewster, R.J. Black, G.J. Macfarlane National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study J Rheumatol 30 5 2003 958 965
13. J.M. Esdaile, M. Abrahamowicz, T. Grodzicky Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus Arthritis Rheum 44 10 2001 2331 2337
14. A. Naranjo, T. Sokka, M.A. Descalzo Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study Arthritis Res Ther 10 2 2008 R30
15. D.H. Solomon, J. Kremer, J.R. Curtis Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity Ann Rheum Dis 69 11 2010 1920 1925
16. L.M. Fischer, R.G. Schlienger, C. Matter, H. Jick, C.R. Meier Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction Am J Cardiol 93 2 2004 198 200
17. I.N. Bruce, M.B. Urowitz, D.D. Gladman, D. Ibanez, G. Steiner Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study Arthritis Rheum 48 11 2003 3159 3167
18. A.J. Yarur, A.R. Deshpande, D.M. Pechman, L. Tamariz, M.T. Abreu, D.A. Sussman Inflammatory bowel disease is associated with an increased incidence of cardiovascular events Am J Gastroenterol 106 4 2011 741 747
19. C. Ha, S. Magowan, N.A. Accortt, J. Chen, C.D. Stone Risk of arterial thrombotic events in inflammatory bowel disease Am J Gastroenterol 104 6 2009 1445 1451
20. M.T. Osterman, Y.X. Yang, C. Brensinger, K.A. Forde, G.R. Lichtenstein, J.D. Lewis No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease Clin Gastroenterol Hepatol 9 10 2011 875 880
21. T.P. Zwaka, V. Hombach, J. Torzewski C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis Circulation 103 9 2001 1194 1197
22. S. Kaptoge, E. Di Angelantonio, G. Lowe C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis Lancet 375 9709 2010 132 140
23. I.M. Graham, L.E. Daly, H.M. Refsum Plasma homocysteine as a risk factor for vascular disease The European Concerted Action Project JAMA 277 22 1997 1775 1781
24. O. Nygard, J.E. Nordrehaug, H. Refsum, P.M. Ueland, M. Farstad, S.E. Vollset Plasma homocysteine levels and mortality in patients with coronary artery disease N Engl J Med 337 4 1997 230 236
25. J.M. Armitage, L. Bowman, R.J. Clarke Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial JAMA 303 24 2010 2486 2494
26. S. Danese, A. Sgambato, A. Papa Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease Am J Gastroenterol 100 4 2005 886 895
27. J. Romagnuolo, R.N. Fedorak, V.C. Dias, F. Bamforth, M. Teltscher Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study Am J Gastroenterol 96 7 2001 2143 2149
28. J.G. Ray Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease Arch Intern Med 158 19 1998 2101 2106
29. S. Saibeni, M. Cattaneo, M. Vecchi Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants Am J Gastroenterol 98 1 2003 112 117
30. E.P. Chiang, D.E. Smith, J. Selhub, G. Dallal, Y.C. Wang, R. Roubenoff Inflammation causes tissue-specific depletion of vitamin B6 Arthritis Res Ther 7 6 2005 R1254 R1262
31. K. Robinson, E.L. Mayer, D.P. Miller Hyperhomocysteinemia and low pyridoxal phosphate Common and independent reversible risk factors for coronary artery disease Circulation 92 10 1995 2825 2830
32. A.R. Folsom, F.J. Nieto, P.G. McGovern Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study Circulation 98 3 1998 204 210
33. K. Dalery, S. Lussier-Cacan, J. Selhub, J. Davignon, Y. Latour, J. Genest Jr Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate Am J Cardiol 75 16 1995 1107 1111
34. L. Chasan-Taber, J. Selhub, I.H. Rosenberg A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians J Am Coll Nutr 15 2 1996 136 143
35. A. Tavani, C. Pelucchi, M. Parpinel, E. Negri, C. La Vecchia Folate and vitamin B(6) intake and risk of acute myocardial infarction in Italy Eur J Clin Nutr 58 9 2004 1266 1272
36. J.H. Page, J. Ma, S.E. Chiuve Plasma vitamin B(6) and risk of myocardial infarction in women Circulation 120 8 2009 649 655
37. S. Friso, D. Girelli, N. Martinelli Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk Am J Clin Nutr 79 6 2004 992 998
38. C.M. Albert, N.R. Cook, J.M. Gaziano Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial JAMA 299 17 2008 2027 2036
39. J.F. Toole, M.R. Malinow, L.E. Chambless Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial JAMA 291 5 2004 565 575
40. K.H. Bonaa, I. Njolstad, P.M. Ueland Homocysteine lowering and cardiovascular events after acute myocardial infarction N Engl J Med 354 15 2006 1578 1588
41. S. Kamath, A.D. Blann, G.Y. Lip Platelet activation: assessment and quantification Eur Heart J 22 17 2001 1561 1571
42. S.G. Chu, R.C. Becker, P.B. Berger Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis J Thromb Haemost 8 1 2010 148 156
43. A.N. Kapsoritakis, M.I. Koukourakis, A. Sfiridaki Mean platelet volume: a useful marker of inflammatory bowel disease activity Am J Gastroenterol 96 3 2001 776 781
44. I.E. Koutroubakis, A. Sfiridaki, G. Tsiolakidou Genetic risk factors in patients with inflammatory bowel disease and vascular complications: case-control study Inflamm Bowel Dis 13 4 2007 410 415
45. B. Mutlu, C.M. Ermeydan, F. Enc Acute myocardial infarction in a young woman with severe ulcerative colitis Int J Cardiol 83 2 2002 183 185
46. T. Freilinger, E. Riedel, M. Holtmannspotter, M. Dichgans, N. Peters Ischemic stroke and peripheral arterial thromboembolism in a patient with Crohn's disease: a case presentation J Neurol Sci 266 1-2 2008 177 179
47. S.D. Dorn, R.S. Sandler Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis Am J Gastroenterol 102 3 2007 662 667
48. N. Dagli, O.K. Poyrazoglu, A.F. Dagli Is inflammatory bowel disease a risk factor for early atherosclerosis? Angiology 61 2 2010 198 204
49. J. Haapamaki, R.P. Roine, U. Turunen, M.A. Farkkila, P.E. Arkkila Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease J Crohns Colitis 5 1 2011 41 47
50. C.N. Bernstein, A. Wajda, J.F. Blanchard The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study Clin Gastroenterol Hepatol 6 1 2008 41 45
51. A.R. Sridhar, S. Parasa, U. Navaneethan, M.D. Crowell, K. Olden Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients J Crohns Colitis 5 4 2011 287 294
52. R. Hayashi, H. Wada, K. Ito, I.M. Adcock Effects of glucocorticoids on gene transcription Eur J Pharmacol 500 1-3 2004 51 62
53. J.P. Girod, D.J. Brotman Does altered glucocorticoid homeostasis increase cardiovascular risk? Cardiovasc Res 64 2 2004 217 226
54. L. Wei, T.M. MacDonald, B.R. Walker Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease Ann Intern Med 141 10 2004 764 770
55. V. Panteris, A. Perdiou, V. Tsirimpis, D.G. Karamanolis Acute coronary syndrome after infliximab therapy in a patient with Crohn's disease World J Gastroenterol 12 38 2006 6235 6238
56. R.A. Waite, J.M. Malinowski Possible mesalamine-induced pericarditis: case report and literature review Pharmacotherapy 22 3 2002 391 394
57. C. Baigent, L. Blackwell, R. Collins Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet 373 9678 2009 1849 1860
58. D. Vadada, J. Vinod, N. Sonpal, P. Baiocco, B. Korelitz Inflammatory bowel disease exacerbations after the initiation of aspirin and clopidogrel (Plavix) - a retrospective case control study Am J Gastroenterol 105 2011 S472 S473
59. B. Kwak, F. Mulhaupt, S. Myit, F. Mach Statins as a newly recognized type of immunomodulator Nat Med 6 12 2000 1399 1402
60. S.D. Crockett, R.A. Hansen, T. Stürmer Statins are associated with reduced use of steroids in inflammatory bowel disease: a retrospective cohort study Inflamm Bowel Dis 18 6 2012 1048 1056
61. O. Grip, S. Janciauskiene, A. Bredberg Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease Br J Pharmacol 155 7 2008 1085 1092
62. Effects of enalapril on mortality in severe congestive heart failure Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group N Engl J Med 316 23 1987 1429 1435
63. R. Jaszewski, V. Tolia, M.N. Ehrinpreis Increased colonic mucosal angiotensin I and II concentrations in Crohn's colitis Gastroenterology 98 6 1990 1543 1548
64. D. Wengrower, G. Zanninelli, O. Pappo Prevention of fibrosis in experimental colitis by captopril: the role of tgf-beta1 Inflamm Bowel Dis 10 5 2004 536 545